# US 2025/0144344 A1 · Conduit headgear connector for patient interface

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0144344 A1
- Document ID: US20250144344A1
- Status: Published application
- Kind: A1
- Application number: 19/020,253
- Filed: 2025-01-14
- Published: 2025-05-08
- Earliest claimed: 2017-12-22
- Assignees: ResMed Pty Ltd
- Applicants: ResMed Pty Ltd
- Inventors: Ravikumar BALUCHAGI; Lachlan Richard GOLDSPINK; Nookarajesh Varma SANGADI; Matthew EVES
- Web page: https://patentgrep.com/patent/US20250144344A1

## CPC

- A61M 16/0622: {having an underlying cushion}
- A61M 16/0069: {the speed thereof being controlled by respiratory parameters, e.g. by inhalation}
- A61M 16/0605: {Means for improving the adaptation of the mask to the patient}
- A61M 16/0616: {with face sealing means comprising a flap or membrane projecting inwards, such that sealing increases with increasing inhalation gas pressure}
- A61M 16/0633: {with forehead support}
- A61M 16/0666: {Nasal cannulas or tubing (devices for improving normal breathing through the nose A61F5/08; nose filters A62B23/06; outside holding devices A61M25/02)}
- A61M 16/0683: {Holding devices therefor}
- A61M 16/0816: {Joints or connectors}
- A61M 16/0875: {Connecting tubes}
- A61M 16/208: {Non-controlled one-way valves, e.g. exhalation, check, pop-off non-rebreathing valves}
- A61M 16/0051: {with alarm devices}
- A61M 16/024: {including calculation means, e.g. using a processor}
- A61M 16/0611: {with a gusset portion}
- A61M 16/0825: {with ball-sockets}
- A61M 16/1055: {bacterial}
- A61M 16/1065: {in the expiratory path}
- A61M 16/109: {the humidifying liquid or the beneficial agent}
- A61M 16/1095: {in the connecting tubes}
- A61M 16/161: {with means for measuring the humidity}
- A61M 16/209: {Relief valves}
- A61M 2016/0027: {pressure meter}
- A61M 2016/003: {with a flowmeter}
- A61M 2205/21: insensitive to tilting or inclination, e.g. spill-over prevention
- A61M 2205/3331: Pressure; Flow
- A61M 2205/3368: Temperature
- A61M 2205/3553: remote, e.g. between patient's home and doctor's office
- A61M 2205/3584: using modem, internet or Bluetooth®
- A61M 2205/3592: using telemetric means, e.g. radio or optical transmission
- A61M 2205/42: Reducing noise
- A61M 2205/502: User interfaces, e.g. screens or keyboards
- A61M 2205/505: Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
- A61M 2230/63: Motion, e.g. physical activity
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

A patient interface may include: a plenum chamber at least partly defining a patient interface chamber, a seal-forming structure constructed and arranged to form a seal with a region of the patient's face, at least one conduit, at least one conduit connector configured to pneumatically connect the at least one conduit to the plenum chamber to provide a flow of air at a therapeutic pressure to the patient interface chamber for breathing by the patient, and a positioning and stabilising structure to provide a force to hold the seal-forming structure on the patient's head, the positioning and stabilising structure comprising at least one tie, wherein the at least one conduit connector includes an anti-asphyxia valve configured to allow the patient to breath from ambient through their mouth in the absence of a flow of pressurised air.

## Claims

### Claim 1

A patient interface comprising:
a plenum chamber at least partly forming a patient interface chamber that is pressurisable to a therapeutic pressure of at least 6 cmH2O above ambient air pressure, the plenum chamber including a first plenum chamber hole and a second plenum chamber hole, the first plenum chamber hole and the second plenum chamber hole each being sized and structured to receive a flow of air at the therapeutic pressure for breathing by a patient,
a seal-forming structure constructed and arranged to form a seal with a region of the patient's face surrounding an entrance to the patient's airways, said seal-forming structure having at least one hole therein such that the flow of air at the therapeutic pressure is delivered to at least an entrance to the patient's nares, the seal-forming structure constructed and arranged to maintain the therapeutic pressure in the patient interface chamber throughout the patient's respiratory cycle in use;
a first conduit and a second conduit each being sized and structured to receive the flow of air at the therapeutic pressure for breathing by the patient;
a first conduit connector configured to pneumatically connect the first conduit to the first plenum chamber hole to provide the flow of air at the therapeutic pressure to the patient interface chamber for breathing by the patient and a second conduit connector configured to pneumatically connect the second conduit to the second plenum chamber hole to provide the flow of air at the therapeutic pressure to the patient interface chamber for breathing by the patient; and
a positioning and stabilising structure to provide a force to hold the seal-forming structure in a therapeutically effective position on the patient's head, the positioning and stabilising structure comprising at least one tie,
wherein the first conduit connector and the second conduit connector each includes an anti-asphyxia valve that is configured to allow the patient to breath from ambient through their mouth in the absence of a flow of pressurised air through the first plenum chamber hole and the second plenum chamber hole.

### Claim 2 (depends on 1)

The patient interface of claim 1, wherein the anti-asphyxia valve in each of the first conduit connector and the second conduit connector includes an anti-asphyxia valve hole.

### Claim 3 (depends on 2)

The patient interface of claim 2, wherein each anti-asphyxia valve hole is shaped and dimensioned to allow the patient to breathe therethrough if the other anti-asphyxia valve hole is occluded.

### Claim 4 (depends on 3)

The patient interface of claim 3, wherein the anti-asphyxia valve in each of the first conduit connector and the second conduit connector further comprises an anti-asphyxia valve flap.

### Claim 5 (depends on 4)

The patient interface of claim 4, wherein the anti-asphyxia valve flap of each of the first conduit connector and the second conduit connector is configured to occlude the anti-asphyxia valve hole of a corresponding one of the first conduit connector and the second conduit connector in a closed position such that the flow of air at the therapeutic pressure traveling through a corresponding one of the first conduit connector and the second conduit connector is directed to the patient interface chamber and prevented from escaping to atmosphere via the anti-asphyxia valve hole during the patient's entire respiratory cycle.

### Claim 6 (depends on 5)

The patient interface of claim 5, wherein, in an open position, the anti-asphyxia valve flap of each of the first conduit connector and the second conduit connector is configured to allow the patient to breath from ambient through their mouth via the anti-asphyxia valve hole of a corresponding one of the first conduit connector and the second conduit connector in the absence of a flow of pressurised air through the first plenum chamber hole and the second plenum chamber hole.

### Claim 7 (depends on 6)

The patient interface of claim 6, wherein the anti-asphyxia valve hole of each of the first conduit connector and the second conduit connector is divided by an anti-asphyxia valve hole divider that prevents the corresponding anti-asphyxia valve flap from passing through the anti-asphyxia valve hole.

### Claim 8 (depends on 7)

The patient interface of claim 7, wherein each anti-asphyxia valve flap further comprises at least one vent hole to allow a portion of the flow of air at the therapeutic pressure to escape to atmosphere therethrough.

### Claim 9 (depends on 8)

The patient interface of claim 8, wherein the anti-asphyxia valve of each of the first conduit connector and the second conduit connector further comprises an anti-asphyxia valve flap connector hole, and
wherein the anti-asphyxia valve flap of each of the first conduit connector and the second conduit connector further comprises an anti-asphyxia valve flap connector to connect the anti-asphyxia valve flap to the anti-asphyxia valve flap connector hole the anti-asphyxia valve of a corresponding one of the first conduit connector and the second conduit connector.

### Claim 10 (depends on 1)

The patient interface of claim 1, wherein the anti-asphyxia valve of each of the first conduit connector and the second conduit connector is configured to operate independently of the other.

### Claim 11 (depends on 1)

The patient interface of claim 1, wherein each of the first conduit connector and the second conduit connector further comprises at least one conduit connector vent hole that is configured to allow a continuous flow of gases exhaled by the patient from an interior of the patient interface chamber to ambient, the at least one conduit connector vent hole being sized and shaped to maintain the therapeutic pressure in the patient interface chamber in use.

### Claim 12 (depends on 11)

The patient interface of claim 11, wherein each of the first conduit connector and the second conduit connector further comprises a conduit connector vent inlet that is configured to direct the continuous flow of gases exhaled by the patient from the interior of the patient interface chamber to the at least one conduit connector vent hole.

### Claim 13 (depends on 12)

The patient interface of claim 12, wherein each of the first conduit connector and the second conduit connector further comprises a conduit connector vent outlet that is configured to direct the continuous flow of gases exhaled by the patient from the at least one conduit connector vent hole to atmosphere.

### Claim 14 (depends on 13)

The patient interface of claim 13, wherein each of the first conduit connector and the second conduit connector further comprises a baffle to prevent the flow of air at the therapeutic pressure passing through each of the first conduit connector and the second conduit connector from passing directly to atmosphere via the at least one conduit connector vent hole.

### Claim 15 (depends on 14)

The patient interface of claim 14, wherein each of the first conduit connector and the second conduit connector further comprises a diffuser cavity containing a diffuser material.

### Claim 16 (depends on 15)

The patient interface of claim 15, wherein the diffuser cavity and the diffuser material is positioned downstream of the at least one conduit connector vent hole relative to the continuous flow of gases to diffuse the continuous flow of gases before escaping to atmosphere.

### Claim 17 (depends on 16)

The patient interface of claim 16, wherein each of the first conduit connector and the second conduit connector further comprises a diffuser cover that encloses the diffuser material within the diffuser cavity.

### Claim 18 (depends on 17)

The patient interface of claim 17, wherein the diffuser cover is removable to allow removal and replacement of the diffuser material.

### Claim 19 (depends on 18)

The patient interface of claim 18, wherein each of the first conduit connector and the second conduit connector further comprises a conduit connector vent outlet that is positioned such that at least a portion of the continuous flow of gases passes through the diffuser material before escaping to atmosphere via the conduit connector vent outlet.

### Claim 20 (depends on 19)

The patient interface of claim 19, wherein each of the first conduit connector and the second conduit connector further comprises a conduit connector spacer to maintain a gap between a portion of each of the first conduit connector and the second conduit connector and the plenum chamber to allow the continuous flow of gases to escape from each of the first conduit connector and the second conduit connector to atmosphere.
